임상시험 현황 데이터

전체 등록 임상시험

최근 갱신: 2026-07-17 15:49:12 (서버 기준).

최근 FDA 승인된 의약품

최근 3상 완료 임상시험

ClinicalTrials.gov 검색 결과

• NCT07244770진행중(모집 종료)관찰 연구
  The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
• NCT06904066모집중중재 연구Phase 1
  Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
• NCT07726082모집중중재 연구해당 없음(NA)
  Micro-choice-based Intervention for Multicausal Fatigue
• NCT03223753완료중재 연구Phase 3
  Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
• NCT01696994진행중(모집 종료)중재 연구해당 없음(NA)
  Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
• NCT06316739진행중(모집 종료)중재 연구해당 없음(NA)
  The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
• NCT07726199모집중중재 연구해당 없음(NA)
  Study Comparing Different Neck Treatment Approaches in Patients With Oral Cancer Without Visible Neck Spread
• NCT07332507모집중중재 연구Phase 1
  Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
• NCT07494734초대 등록중재 연구해당 없음(NA)
  MANUAL THERAPY ON PAIN, DISABILITY AND QUALITY OF LIFE
• NCT06487481모집중중재 연구Phase 1
  Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
• NCT07726004모집 전중재 연구해당 없음(NA)
  Development of an Alcohol, Cannabis, and Sexual Assault Risk Reduction Program for High Risk College Women
• NCT00565344완료관찰 연구
  Medicaid Disenrollment: Intrastate Emergency Department Impact
• NCT07725705모집 전중재 연구Phase 1, Phase 2
  SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Peripheral T-cell Lymphoma (PTCL)
• NCT07561346완료관찰 연구
  Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer
• NCT03219359모집중중재 연구Phase 2
  Autologous Stem Cell Transplant for Crohn's Disease
• NCT05201066진행중(모집 종료)중재 연구Phase 2
  Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
• NCT04203173완료중재 연구해당 없음(NA)
  Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1
• NCT07725562모집중중재 연구Phase 2, Phase 3
  Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of VG081821AC Tablets in Patients With Early to Mid-stage Parkinson's Disease
• NCT07725146모집중관찰 연구
  Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire
• NCT07190794조기 종료관찰 연구
  RESCUE: Discontinuation of GLP-1

ClinicalTrials.gov에서 더 검색하기